(Q81283549)
Statements
A randomized, multicentre, open-label, parallel-group trial of the tolerability of interferon beta-1a (Rebif) administered by autoinjection or manual injection in relapsing-remitting multiple sclerosis (English)
D Mikol
M Lopez-Bresnahan
S Taraskiewicz
P Chang
J Rangnow
Rebiject Study Group